Funds and ETFs Vimian Group AB

Equities

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:29:39 2024-05-13 am EDT 5-day change 1st Jan Change
34.35 SEK +1.18% Intraday chart for Vimian Group AB +10.81% +16.05%

ETFs positioned on Vimian Group AB

Name Weight AuM 1st Jan change Investor Rating
0.01% 746 M€ -.--% -
0.00% 10 M€ -3.35% -
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
2.909 EUR
Average target price
3.372 EUR
Spread / Average Target
+15.93%
Consensus
  1. Stock Market
  2. Equities
  3. VIMIAN Stock
  4. Funds and ETFs Vimian Group AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW